Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application
Yan Zhang,1 Qian Han,2 Yusha Ru,1 Qiyu Bo,1 Rui Hua Wei1 1Tianjin Medical University Eye Hospital, Tianjin Medical University Eye Institute, College of Optometry and Ophthalmology, Tianjin Medical University, Tianjin, 2Tangshan Eye Hospital, Tangshan, Hebei Province, People’s Republic of...
Main Authors: | Zhang Y, Han Q, Ru Y, Bo Q, Wei RH |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-07-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/anti-vegf-treatment-for-myopic-choroid-neovascularization-from-molecul-peer-reviewed-article-DDDT |
Similar Items
-
Macular density alterations in myopic choroidal neovascularization and the effect of anti-VEGF on it
by: Jian-Bo Mao, et al.
Published: (2021-08-01) -
Biomarkers of Myopic Choroidal Neovascularization in Women, Determining the Clinical Course and Response to Anti-VEGF Therapy
by: A. V. Grigorieva, et al.
Published: (2021-06-01) -
Analysis on macular choroidal thickness of patients with myopic choroidal neovascularization
by: Yan Qiu, et al.
Published: (2015-05-01) -
Single intravitreal ranibizumab for myopic choroidal neovascularization
by: Shatriah I, et al.
Published: (2011-08-01) -
Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization
by: Tan CS, et al.
Published: (2017-09-01)